Latest Period
Q4 2025
Security Snapshot
ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) Institutional Ownership
CUSIP: 68752L100
13F Institutional Holders and Ownership History from Q4 2017 to Q1 2026
Institutions Reporting
120
Shares (Excl. Options)
16,313,355
Price
$17.76
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Class A common stock, $0.00025 par value
- Symbol
- KIDS on Nasdaq
- Shares outstanding
- 25,086,311
- Price per share
- $15.94
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 16,313,355
- Total reported value
- $289,753,004
- % of total 13F portfolios
- 0%
- Share change
- -204,044
- Value change
- -$4,111,125
- Number of holders
- 120
- Price from insider filings
- $15.94
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- KIDS - ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value is tracked under CUSIP 68752L100.
- 120 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 120 to 43 between Q4 2025 and Q1 2026.
- Reported value moved from $289,753,004 to $55,629,768.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 120 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 68752L100?
CUSIP 68752L100 identifies KIDS - ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68752L100:
Significant Owners of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC | 5.5% | $25,768,856 | 1,390,656 | Millennium Management LLC | 29 Oct 2025 | |||
| BlackRock, Inc. | 5% | $26,436,748 | 1,230,784 | BlackRock, Inc. | 30 Jun 2025 | |||
| BROWN CAPITAL MANAGEMENT LLC | 4.3% | -35% | $20,035,007 | -$10,919,822 | 1,081,220 | -35% | Brown Capital Management, LLC | 30 Sep 2025 |
As of 31 Dec 2025, 120 institutional investors reported holding 16,313,355 shares of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS). This represents 65% of the company’s total 25,086,311 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BROWN ADVISORY INC | 7.5% | 1,890,886 | -0.2% | 0.05% | $33,582,137 |
| MILLENNIUM MANAGEMENT LLC | 5.6% | 1,396,495 | +48% | 0.02% | $24,801,751 |
| BlackRock, Inc. | 4.7% | 1,190,382 | -2.2% | 0% | $21,141,185 |
| MORGAN STANLEY | 4.4% | 1,116,141 | +0.42% | 0% | $19,822,664 |
| BRAIDWELL LP | 4.4% | 1,100,370 | -0.67% | 0.62% | $19,542,571 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.1% | 1,019,696 | -0.47% | 0% | $18,109,801 |
| VANGUARD GROUP INC | 3.9% | 970,445 | +0.95% | 0% | $17,235,104 |
| Granahan Investment Management, LLC | 2.6% | 663,981 | -13% | 0.5% | $11,792,303 |
| DIMENSIONAL FUND ADVISORS LP | 2.5% | 622,419 | -14% | 0% | $11,054,513 |
| Soleus Capital Management, L.P. | 2.1% | 525,447 | +311% | 0.4% | $9,331,939 |
| BROWN CAPITAL MANAGEMENT LLC | 2% | 514,097 | -52% | 0.75% | $9,130,363 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 410,569 | -1.7% | 0% | $7,292,909 |
| STATE STREET CORP | 1.6% | 395,410 | -7.4% | 0% | $7,022,482 |
| WASATCH ADVISORS LP | 1.2% | 289,869 | -4.7% | 0.03% | $5,148,073 |
| RIVERBRIDGE PARTNERS LLC | 1.1% | 268,265 | -8.7% | 0.09% | $4,764,391 |
| Roubaix Capital, LLC | 0.93% | 234,323 | 1.8% | $4,161,576 | |
| AWM Investment Company, Inc. | 0.85% | 214,169 | -61% | 0.37% | $3,803,641 |
| Nantahala Capital Management, LLC | 0.8% | 199,449 | +303% | 0.21% | $3,542,214 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.72% | 181,743 | +9.8% | 0.07% | $3,227,756 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 0.71% | 178,272 | -0.63% | 0.03% | $3,166,111 |
| GOLDMAN SACHS GROUP INC | 0.69% | 174,146 | +113% | 0% | $3,092,833 |
| NORTHERN TRUST CORP | 0.62% | 155,252 | -11% | 0% | $2,757,276 |
| CITADEL ADVISORS LLC | 0.61% | 152,611 | +1260% | 0% | $2,710,372 |
| Triodos Investment Management BV | 0.59% | 147,000 | +11% | 0.19% | $2,640,120 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0.57% | 144,220 | -26% | 0.03% | $2,561,347 |
Institutional Holders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,505,579 | $55,629,768 | +$3,343,409 | $15.87 | 43 |
| 2025 Q4 | 16,313,355 | $289,753,004 | -$4,111,125 | $17.76 | 120 |
| 2025 Q3 | 16,501,828 | $305,775,919 | -$6,455,185 | $18.53 | 110 |
| 2025 Q2 | 16,817,981 | $361,248,552 | +$2,212,295 | $21.48 | 116 |
| 2025 Q1 | 16,691,588 | $411,125,012 | +$5,143,009 | $24.63 | 114 |
| 2024 Q4 | 16,501,406 | $382,504,159 | +$773,471 | $23.18 | 107 |
| 2024 Q3 | 16,333,743 | $442,837,473 | +$1,584,968 | $27.11 | 121 |
| 2024 Q2 | 16,242,247 | $467,138,707 | +$10,095,978 | $28.76 | 120 |
| 2024 Q1 | 15,892,946 | $463,440,165 | -$12,906,846 | $29.16 | 117 |
| 2023 Q4 | 16,261,994 | $528,667,001 | -$251,450 | $32.51 | 126 |
| 2023 Q3 | 16,271,554 | $521,018,497 | +$6,205,213 | $32.00 | 115 |
| 2023 Q2 | 15,984,589 | $701,031,443 | -$10,062,157 | $43.85 | 120 |
| 2023 Q1 | 16,213,938 | $717,721,563 | +$13,280,226 | $44.29 | 120 |
| 2022 Q4 | 15,969,552 | $634,638,489 | -$20,370,351 | $39.73 | 117 |
| 2022 Q3 | 15,319,596 | $706,913,920 | +$7,022,250 | $46.14 | 120 |
| 2022 Q2 | 15,147,316 | $653,533,661 | +$9,822,525 | $43.15 | 112 |
| 2022 Q1 | 14,882,764 | $803,548,443 | +$23,227,965 | $53.99 | 121 |
| 2021 Q4 | 14,446,519 | $864,710,320 | -$43,598,809 | $59.86 | 123 |
| 2021 Q3 | 14,787,776 | $968,927,802 | -$16,120,535 | $65.51 | 140 |
| 2021 Q2 | 15,040,814 | $950,122,354 | +$34,742,154 | $63.18 | 136 |
| 2021 Q1 | 14,650,983 | $714,225,765 | -$10,678,703 | $48.75 | 122 |
| 2020 Q4 | 15,132,644 | $624,376,779 | +$44,734,958 | $41.25 | 130 |
| 2020 Q3 | 13,957,347 | $640,952,762 | +$41,183,608 | $45.92 | 122 |
| 2020 Q2 | 13,071,781 | $571,934,696 | +$88,263,492 | $43.76 | 127 |
| 2020 Q1 | 11,071,736 | $438,826,875 | +$57,686,504 | $39.64 | 104 |
| 2019 Q4 | 9,512,953 | $446,965,037 | +$84,907,154 | $46.99 | 104 |
| 2019 Q3 | 7,509,308 | $264,801,326 | +$8,203,360 | $35.26 | 88 |
| 2019 Q2 | 7,203,561 | $280,872,895 | +$1,251,778 | $39.00 | 98 |
| 2019 Q1 | 7,148,503 | $316,165,724 | +$23,434,585 | $44.23 | 93 |
| 2018 Q4 | 6,630,503 | $231,241,733 | +$50,275,283 | $34.88 | 75 |
| 2018 Q3 | 5,186,095 | $189,981,535 | +$5,589,115 | $36.64 | 63 |
| 2018 Q2 | 5,138,887 | $136,915,101 | +$18,977,050 | $26.64 | 55 |
| 2018 Q1 | 4,514,822 | $67,993,229 | +$3,724,248 | $15.06 | 46 |
| 2017 Q4 | 4,158,182 | $79,791,894 | +$79,791,894 | $19.19 | 49 |